Details for New Drug Application (NDA): 207875
✉ Email this page to a colleague
The generic ingredient in ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 207875
Tradename: | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE |
Applicant: | Sun Pharm |
Ingredient: | albuterol sulfate; ipratropium bromide |
Patents: | 0 |
Pharmacology for NDA: 207875
Mechanism of Action | Adrenergic beta2-Agonists Cholinergic Antagonists |
Suppliers and Packaging for NDA: 207875
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 207875 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-756 | 47335-756-49 | 6 POUCH in 1 CARTON (47335-756-49) / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL |
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 207875 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-756 | 47335-756-52 | 12 POUCH in 1 CARTON (47335-756-52) / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.083% BASE;0.017% | ||||
Approval Date: | Aug 7, 2017 | TE: | AN | RLD: | No |
Complete Access Available with Subscription